Effect of autoimmune diseases on risk and survival in histology-specific lung cancer

Keyphrases

• Lung Cancer 100%
• Autoimmune Disease 100%
• Histology-agnostic 100%
• Standardized Incidence Ratio 33%
• Standardized Mortality Ratio 25%
• Hazard Ratio 16%
• Cancer Mortality 16%
• Lung Cancer Risk 16%
• Copyright 8%
• Dysregulation 8%
• Mortality Hazard 8%
• Cancer-specific Survival 8%
• Systemic Lupus Erythematosus 8%
• Cancer Risk 8%
• Dermatomyositis 8%
• Small Cell Carcinoma 8%
• Immune System 8%
• Rheumatic Fever 8%
• Cancer Inpatients 8%
• Cancer Incidence 8%
• Systemic Sclerosis 8%
• Autoimmune Process 8%
• Discoid Lupus Erythematosus 8%
• Immune Treatment 8%
• Lung Manifestation 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Cancer 100%
• Autoimmune Disease 100%
• Standardized Incidence Ratio 33%
• Standardized Mortality Ratio 25%
• Cancer Mortality 16%
• Malignant Neoplasm 8%
• Overall Survival 8%
• Cancer Incidence 8%
• Systemic Sclerosis 8%
• Cancer Survival 8%
• Small Cell Carcinoma 8%
• Cancer Susceptibility 8%
• Systemic Lupus Erythematosus 8%
• Discoid Lupus Erythematosus 8%
• Dermatomyositis 8%
• Rheumatic Fever 8%

Immunology and Microbiology

• Autoimmune Disease 100%
• Standardized Incidence Ratio 33%
• Standardized Mortality Ratio 25%
• Cancer Mortality 16%
• Autoimmunity 8%
• Cancer Survival 8%
• Overall Survival 8%
• Systemic Lupus Erythematosus 8%
• Cancer Incidence 8%
• Dermatomyositis 8%
• Immune System 8%
• Systemic Scleroderma 8%
• Rheumatic Fever 8%
• Lupus Vulgaris 8%
• Susceptibility 8%